Skip to main content
logo
IREN Limited (IREN)
NASDAQ: IREN · Real-Time Price · USD
15.40
-0.71 (-4.41%)
At close: Aug 1, 2025, 4:00 PM
15.24
-0.16 (-1.04%)
After-hours: Aug 1, 2025, 7:59 PM EDT

CTI BioPharma Revenue

IREN Limited had revenue of $148.10M in the quarter ending March 31, 2025, with 172.49% growth. This brings the company's revenue in the last twelve months to $377.82M, up 128.24% year-over-year. In the fiscal year ending June 30, 2024, IREN Limited had annual revenue of $188.76M with 149.98% growth.

Revenue (ttm)
$377.82M
Revenue Growth
+128.24%
P/S Ratio
7.87
Revenue / Employee
$2,623,757
Employees
144
Market Cap
3.72B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2024188.76M113.25M149.98%
Jun 30, 202375.51M16.47M27.90%
Jun 30, 202259.04M51.14M647.49%
Jun 30, 20217.90M5.72M263.29%
Jun 30, 20202.17M2.17M206,553.99%
Jun 30, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Berkshire Hathaway371.29B
JPMorgan Chase & Co.163.65B
Bank of America98.46B
Wells Fargo & Company77.62B
Morgan Stanley65.61B
American Express Company63.44B
HSBC Holdings56.21B
The Goldman Sachs Group54.79B
Revenue Rankings

IREN News

More News